-
1
Defective Cystic Fibrosis Transmembrane Conductance Regulator Accelerates Skeletal Muscle Aging by Impairing Autophagy/Myogenesis
Published 2025-02-01Subjects: Get full text
Article -
2
-
3
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system
Published 2025-03-01Subjects: “…CFTR modulator…”
Get full text
Article -
4
Optimization of ivacaftor-loaded solid lipid nanoparticles for solubility enhancement
Published 2025-08-01Subjects: “…CFTR modulator…”
Get full text
Article -
5
A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis
Published 2024-09-01Subjects: “…CFTR modulator…”
Get full text
Article -
6
The effect of modulators on lung function following inpatient treatment for CF exacerbations
Published 2025-08-01Subjects: Get full text
Article -
7
-
8
A descriptive cohort study of pregnancy and parenthood in women with cystic fibrosis
Published 2025-07-01Subjects: Get full text
Article -
9
Gallbladder sludge and microlithiasis disappearance in a cystic fibrosis patient 1 year after triple combination therapy initiation
Published 2024-10-01Subjects: “…CFTR modulators…”
Get full text
Article -
10
Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling
Published 2025-03-01Subjects: “…cystic fibrosis transmembrane conductance regulator (CFTR) modulator…”
Get full text
Article -
11
-
12
Clinical Efficacy and Safety of Ivacaftor/Lumacaftor Combination in Patients with Cystic Fibrosis: International Studies Review
Published 2021-12-01Subjects: Get full text
Article -
13
Mejoría de la inflamación intestinal tras tratamiento con moduladores de la proteína CFTR en pacientes con fibrosis quística
Published 2025-05-01Subjects: Get full text
Article -
14
Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator Therapies
Published 2025-07-01Subjects: Get full text
Article -
15
Integrated Approaches to Managing Cystic Fibrosis: From Nutritional Optimization to Therapeutic Advancements
Published 2024-12-01Subjects: Get full text
Article -
16
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review
Published 2024-12-01Subjects: Get full text
Article -
17
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS...
Published 2025-02-01Subjects: “…CFTR modulators…”
Get full text
Article -
18
Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients
Published 2025-02-01Subjects: Get full text
Article -
19
Effect of CFTR modulators on glucose homeostasis in children and young adults with cystic fibrosis-related diabetes: a systematic review
Published 2025-08-01Subjects: Get full text
Article -
20